Home/Filings/4/0001209191-23-026746
4//SEC Filing

KIM AUSTIN D. 4

Accession 0001209191-23-026746

CIK 0001070494other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 7:06 PM ET

Size

8.8 KB

Accession

0001209191-23-026746

Insider Transaction Report

Form 4
Period: 2023-04-29
KIM AUSTIN D.
EVP AND GENERAL COUNSEL
Transactions
  • Sale

    Common Stock

    2023-05-01$21.18/sh917$19,42225,513 total
  • Exercise/Conversion

    Common Stock

    2023-04-29+3,00526,430 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-04-293,0050 total
    Common Stock (3,005 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
  • [F2]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
  • [F3]The restricted stock units vest in four equal annual installments beginning 4/29/2020.

Issuer

ACADIA PHARMACEUTICALS INC

CIK 0001070494

Entity typeother

Related Parties

1
  • filerCIK 0001746240

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 7:06 PM ET
Size
8.8 KB